BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2081876)

  • 21. Endocervical curettage in the evaluation of cervical disease in patients with adequate colposcopy.
    Soisson AP; Molina CY; Benson WL
    Obstet Gynecol; 1988 Jan; 71(1):109-11. PubMed ID: 3336531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of endocervical curettage in evaluating abnormal cervical cytology.
    Drescher CW; Peters WA; Roberts JA
    Obstet Gynecol; 1983 Sep; 62(3):343-7. PubMed ID: 6877690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of endocervical curettage (ECC) in predicting neoplastic lesions of the cervix].
    Toki T; Fujii S; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):265-70. PubMed ID: 8133138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of endocervical canal in women with minimal cervical cytological abnormalities.
    Goksedef BP; Akbayir O; Numanoglu C; Corbacioglu A; Guraslan H; Bakir LV; Kaya O; Yanik G; Cetin A
    J Low Genit Tract Dis; 2013 Jul; 17(3):261-6. PubMed ID: 23422642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocervical curettage at the time of colposcopic assessment of the uterine cervix.
    Abu J; Davies Q
    Obstet Gynecol Surv; 2005 May; 60(5):315-20. PubMed ID: 15841025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of normal colposcopy after an abnormal cervical smear report.
    Luesley D; Downey G
    J Low Genit Tract Dis; 2009 Jan; 13(1):33-7. PubMed ID: 19098604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial and endocervical curettage findings at the time of cervical conization.
    Presley JJ; Hernandez E; Mudafort E; Miyazawa K
    J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic variables predictive of residual dysplasia after cervical conization.
    Schermerhorn TJ; Hodge J; Saltzman AK; Hackett TE; Sprance HE; Harrison TA
    J Reprod Med; 1997 Apr; 42(4):189-92. PubMed ID: 9131490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive cancer following outpatient evaluation and therapy for cervical disease.
    Townsend DE; Richart RM; Marks E; Nielsen J
    Obstet Gynecol; 1981 Feb; 57(2):145-9. PubMed ID: 7465117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients with positive margins after cervical conization.
    Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
    Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia.
    Barlin JN; Bristow RE; Murillo AM; Zahurak M; Veras E; Salani R
    J Reprod Med; 2010; 55(3-4):129-33. PubMed ID: 20506673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of cervical cryotherapy with inadequate follow-up colposcopy.
    Sparks RA; Scheid D; Loemker V; Stader E; Reilly K; Hamm R; McCarthy L
    J Fam Pract; 2002 Jun; 51(6):526-9. PubMed ID: 12100775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pap smears with reactive cellular changes: a prospective study.
    Ding DC; Hsu S; Chen SS; Hsu YH
    J Reprod Med; 2007 Oct; 52(10):938-40. PubMed ID: 17977169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of endocervical curettage in the screening for cervical cancer: apropos of a series of 31 cases].
    Ayoubi JM; Cayrol MH; Meddoun M; Benevent JB; Degoy J; Pons JC
    Gynecol Obstet Fertil; 2000 Jun; 28(6):455-9. PubMed ID: 10935311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocervical curettage: does it contribute to the management of patients with abnormal cervical cytology?
    Oyer R; Hanjani P
    Gynecol Oncol; 1986 Oct; 25(2):204-11. PubMed ID: 3758830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of the factors involved in the colposcopic evaluation of 2194 patients with abnormal Papanicolaou smears.
    Wetrich DW
    Am J Obstet Gynecol; 1986 Jun; 154(6):1339-49. PubMed ID: 3717244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical conization findings in women with dysplastic cervical cytology and normal colposcopy.
    Ramirez EJ; Hernandez E; Miyazawa K
    J Reprod Med; 1990 Apr; 35(4):359-61. PubMed ID: 2352226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colposcopic screening of women with atypical Papanicolaou smears.
    Kohan S; Noumoff J; Beckman EM; Morris M; Weiner E; Douglas GW
    J Reprod Med; 1985 May; 30(5):383-7. PubMed ID: 4009560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.